Considering the cross-talk between Notch with multiple pathways, we surmise that the influence of Notch1 on MFS was reduced in patients with advanced stage breast cancer, most likely due to the redundancy and complexity of diverse signaling pathways [8, 15, 22]. Here, NOTCH1 is linked to breast cancer.